Literature DB >> 6351572

Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm.

P H Stone, J E Muller, Z G Turi, E Geltman, A S Jaffe, E Braunwald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6351572     DOI： 10.1016/0002-8703(83)90081-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  12 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  1,4-Dihydropyridines versus beta-blockers for hypertension: are either safe for the heart?

Authors:  F H Leenen
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

3.  Development of tolerance to nifedipine in patients with stable angina pectoris.

Authors:  S Y Martsevich; V I Metelitsa; D O Rumiantsev; V K Piotrovskii; I D Slastnikova; L V Egorov; V A Vygodin
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

Review 4.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

5.  Prevention of vasospastic angina with nicardipine.

Authors:  C J Pepine; J S Gelman
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Coronary vasomotor and clinical effects of nifedipine in effort, mixed and Prinzmental angina.

Authors:  A Polese; N De Cesare; A Bartorelli; F Fabbiocchi; A Loaldi; P Montorsi; M D Guazzi
Journal:  Int J Card Imaging       Date:  1988

Review 7.  Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.

Authors:  Sanjay Kumar; Roger J C Hall
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Preload or afterload reduction: which is more beneficial for patients with ischemic heart disease?

Authors:  D G Caralis; Z Kyriakides
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 9.  Nonresponsiveness to antianginal therapy--a frequent problem?

Authors:  W Schulz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 10.  Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.